Viewing Study NCT00240695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-04-27 @ 3:34 PM
Study NCT ID: NCT00240695
Status: COMPLETED
Last Update Posted: 2011-05-18
First Post: 2005-10-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cognition Disorder View
None Nervous System Diseases View
None Mental Disorders View
None Brain Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alzheimer's disease View
None Dementia View
None Brain Disease View
None Memory Loss View
None galantamine View
None Nervous System Diseases View
None open-label View
None elderly View